Key facts
- This page summarizes Kate McKinley's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 05 Aug 2025, 16:12.
Kate McKinley - 01 Aug 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- RANI
- Reported as of
- 01 Aug 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 Aug 2025, 16:12:53 UTC
- Prior SEC filing
- 23 May 2025
- Next SEC filing
- 05 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Svai Sanford, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kate McKinley filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 05 Aug 2025.
Change
- Previous filing in this sequence was filed on 23 May 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001979211
Primary reporting owner
McKinley Kate
- Relationship
- Chief Business Officer
- Address
- 2051 RINGWOOD AVE, SAN JOSE
- Signature
- /s/ Svai Sanford, Attorney-in-Fact
- Signature date
- 05 Aug 2025
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
RANI
transaction
Derivative
Employee Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +120,000
- Change %
- Price
- $0.000000
- Shares after
- 120,000
- Date
- 01 Aug 2025
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 120,000
- Exercise price
- $0.5280
* marks a reported price that did not pass the local price check.